List view / Grid view
19 October 2015 | By Victoria White
Pfizer’s investigational antibody-drug conjugate inotuzumab ozogamicin has received Breakthrough Therapy designation for acute lymphoblastic leukaemia...
19 October 2015 | By Victoria White
The global treatment market for peripheral artery disease will hit a peak of $983.6 million in 2020, before falling to $816.3 million by 2024 due to the generic erosion of Brilinta and Xarelto...
19 October 2015 | By Victoria White
Praxbind is indicated for patients treated with Pradaxa, when reversal of the anticoagulant effects of Pradaxa is needed for emergency surgery or in uncontrolled bleeding...
19 October 2015 | By Victoria White
Viekirax and Exviera are the first treatments for chronic HCV to combine three direct-acting antiviral agents to target the infection at multiple steps in the viral lifecycle...
16 October 2015 | By Victoria White
Scientists investigating whether the malaria drug artesunate could have a significant impact on colorectal cancer have launched a crowdfunding project to fund their work...
16 October 2015 | By Victoria White
Phase II results show lenvatinib, when used in combination with everolimus, demonstrates significantly improved PFS versus everolimus alone in people with metastatic renal cell carcinoma...
16 October 2015 | By CHI
Largest European Event for Biologics Returns to Lisbon from 2-6 November...
16 October 2015 | By Victoria White
The trials will evaluate the efficacy and safety of intravenous iclaprim versus intravenous vancomycin in the treatment of acute bacterial skin and skin structure infections...
16 October 2015 | By Victoria White
NICE has recommended Daklinza for the treatment of patients with chronic hepatitis C virus genotypes 1, 3 and 4...
16 October 2015 | By Victoria White
Results from an extension study show that long-term onabotulinumtoxinA (Botox) treatment consistently decreased urinary incontinence in female patients...
15 October 2015 | By Sartorius Stedim Biotech
Today, single-use bags are increasingly used in all process steps of biopharmaceutical manufacturing...
15 October 2015 | By Victoria White
In a study, examining the activity of only five genes in a sample of the tumour was enough to identify high-risk children who might benefit from more intensive treatment...
15 October 2015 | By Victoria White
Under the terms of the agreement, Hikma will have the exclusive rights to register, distribute and market Zevtera in all its Middle Eastern and North African markets...
15 October 2015 | By Victoria White
Valeant has also revealed that it has responded to a letter from US Senator Claire McCaskill concerning the price of Nitropress and Isuprel...
15 October 2015 | By Victoria White
As well as an upfront payment of $350 million, Five Prime will be eligible to receive up to $1.05 billion in development and regulatory milestone payments...
